(Q33832749)

29 July 2017

1 reference

title

Clinical teratology: identifying teratogenic risks in humans (English)

1 reference

29 July 2017

0 references

Polifka JE

1

1 reference

PubMed ID

10665659

29 July 2017

Friedman JM

series ordinal

2

1 reference

29 July 2017

1 December 1999

1 reference

29 July 2017

1 reference

29 July 2017

56

1 reference

29 July 2017

6

1 reference

29 July 2017

409-420

1 reference

Angiotensin-converting enzyme inhibitors, an embryopathic class of drugs with unique properties: information for clinical teratology counselors

29 July 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Angiotensin converting enzyme inhibitors in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Teratogen update: fetal hydantoin effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 2: Human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Outcomes of pregnancy associated with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Antiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Maternal and fetal implications of anticonvulsive therapy during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Drugs in pregnancy: anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Fluconazole-induced congenital anomalies in three infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Aminopterin and methotrexate: folic acid deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Methotrexate exposure prior to and during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Medical abortion in early pregnancy: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Adult and two children with fetal methotrexate syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Letter: Teratogenic effects of combination chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

The investigation and management of Hodgkin's disease in the pregnant patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Pregnancy outcome in cancer patients. Experience in a large cooperative group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Teratogen update: methylene blue

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Penicillamine-induced elastosis perforans serpiginosa treated successfully with isotretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

An assessment of lithium using the IEHR Evaluative Process for Assessing Human Developmental and Reproductive Toxicity of Agents. IEHR Expert Scientific Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Teratogen update: vitamin A congeners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Oral retinoids. What should the prescriber known about their teratogenic hazards among women of child-bearing potential?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Neurobehavioral teratology of isotretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Severe limb defects and craniofacial anomalies in a fetus conceived during acitretin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Periconceptional vitamin A use: how much is teratogenic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Vitamin A and its congeners

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Potential risk of birth defects after acitretin discontinuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Recognition of thalidomide defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Current concepts of anticoagulant therapy in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Maternal and fetal sequelae of anticoagulation during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

The medical treatment of culture-negative infective endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Guidelines for Use of Terminology Describing the Impact of Prenatal Alcohol on the Offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Prenatal alcohol exposure and development at preschool age: main results of a French study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Reproductive risks of binge drinking during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

The impact of prenatal cocaine exposure: studies of the developing infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Neurological correlates of fetal cocaine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Annotation: the psychological development and welfare of children of opiate and cocaine users: review and research needs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Induction of mortality and malformation in Xenopus laevis embryos by water sources associated with field frog deformities

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Fetal damage caused by parvoviral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Lues-lues: maternal and fetal considerations of syphilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Type I diabetes mellitus and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Assessment and management of pregnancy complicated by pregestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

The Resource Mothers Program for Maternal Phenylketonuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Limb defects and chorionic villus sampling: results from an international registry, 1992-94.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Contribution of clinical teratologists and geneticists to the evaluation of the etiology of congenital malformations alleged to be caused by environmental agents: ionizing radiation, electromagnetic fields, microwaves, radionuclides, and ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Human teratogens: how can we sort them out?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Molecular mechanisms of genetic polymorphisms of drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Interindividual variations in susceptibility and sensitivity: linking risk assessment and risk management

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Teratology: general considerations and principles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Report of the Teratology Society Public Affairs Committee symposium on FDA classification of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

Differentiation as a determinant of the reaction of rat embryos to X-irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Teratogen update: angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Neonatal anuria by ACE inhibitors during pregnancy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Pregnancy and epilepsy: a retrospective study of 151 pregnancies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.A) administered by the oral route

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

CONGENITAL ANOMALIES PROBABLY INDUCED BY CYCLOPHOSPHAMIDE

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Association between ovulation stimulation, in vitro fertilisation, and neural tube defects?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Ovulation induction and neural tube defects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Ovulation induction and neural tube defects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Ovulation induction by clomiphene and neural tube defects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Clomiphene citrate and neural tube defects: a pooled analysis of controlled epidemiologic studies and recommendations for future studies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Teratogen update: penicillamine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Sertraline for premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Vitamin A and birth defects. Continuing caution is needed

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Anticoagulation and pregnancy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Vitamin K deficiency embryopathy: a phenocopy of the warfarin embryopathy due to a disorder of embryonic vitamin K metabolism

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Neurological Correlates of Fetal Cocaine Exposurea

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Middle-ear disease in children exposed prenatally to polychlorinated biphenyls and polychlorinated dibenzofurans

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Hyperglycemia-induced embryonic dysmorphogenesis correlates with genomic DNA mutation frequency in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Utilization of developmental basic science principles in the evaluation of reproductive risks from pre- and postconception environmental radiation exposures

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Onset of Function in the Human Fetal Thyroid: Biochemical and Radioautographic Studies from Organ Culture1

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Drug exposure during pregnancy: some epidemiologic considerations.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Changing epidemiology of congenital rubella syndrome in the United States

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

Folic acid and the prevention of birth defects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.1999.560601.X

7 January 2021

10.1034/J.1399-0004.1999.560601.X

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10665659